Endo
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 1/3/2024
Pipeline by Phase
Therapeutic Focus
Clinical Trials (49)
Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis
Started: 2/14/2022
Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)
Started: 4/26/2018
Real World CCH Study in Adult Females With Cellulite
Started: 11/1/2019
Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
Started: 4/1/2016
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
Started: 12/13/2010
Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children
Started: 3/11/2013
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Started: 11/17/2008
Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
Started: 2/5/2018
Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women
Started: 2/8/2018
Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.
Started: 2/17/2009
An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
Started: 10/1/2014
Time to Eugonadal Range, Time to Steady State and Drying Time
Started: 11/1/2010
A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
Started: 9/1/2012
Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures
Started: 9/1/2012
Study of AA4500 in the Treatment of Peyronie's Disease
Started: 10/1/2010
Study of AA4500 in the Treatment of Peyronie's Disease
Started: 9/1/2010
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
Started: 5/1/2011
Administration of Two Injections for Multiple Dupuytren's Contractures
Started: 9/1/2011
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
Started: 9/1/2008
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Started: 2/1/2011
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
Started: 10/1/2010
Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
Started: 11/29/2021
A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)
Started: 1/3/2024
Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks
Started: 6/15/2022
Safety and Efficacy of EN3835 in Participants With Frozen Shoulder
Started: 7/29/2020
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
Started: 9/18/2018
CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques
Started: 10/1/2020
Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women
Started: 11/20/2019
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
Started: 11/17/2017
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Started: 10/5/2016
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Started: 2/1/2016
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
Started: 7/1/2014
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Started: 10/1/2013
The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease
Started: 8/1/2008
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
Started: 11/1/2013
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Started: 11/1/2011
Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
Started: 9/1/2011
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
Started: 2/1/2009
Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers
Started: 10/10/2019
Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP
Started: 9/18/2018
The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Started: 1/1/2012
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Started: 10/1/2012
Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome
Started: 7/1/2009
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
Started: 6/30/2020
Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite
Started: 12/28/2020
Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)
Started: 6/1/2009